Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

11.8%

4 terminated/withdrawn out of 34 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

9%

3 trials in Phase 3/4

Results Transparency

50%

10 of 20 completed trials have results

Key Signals

10 with results

Enrollment Performance

Analytics

N/A
17(63.0%)
Phase 2
7(25.9%)
Phase 3
3(11.1%)
27Total
N/A(17)
Phase 2(7)
Phase 3(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (34)

Showing 20 of 34 trials
NCT04165564Active Not Recruiting

DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers

Role: collaborator

NCT02504697Active Not Recruiting

DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer

Role: collaborator

NCT01805076Phase 3Completed

MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer

Role: collaborator

NCT01564368Not ApplicableCompleted

DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy

Role: lead

NCT00794339Phase 2Terminated

Phase II Trial of 64Cu-ATSM PET/CT in Cervical Cancer

Role: collaborator

NCT01082224Not ApplicableUnknown

Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy

Role: lead

NCT01217385Not ApplicableCompleted

Monitoring and Predicting Chemotherapy Response Using DOSI

Role: lead

NCT01257932Withdrawn

Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using Diffuse Optical Spectroscopic Imaging

Role: collaborator

NCT01785342Completed

DECAMP-1: Diagnosis and Surveillance of Indeterminate Pulmonary Nodules

Role: collaborator

NCT01562223Not ApplicableUnknown

Studying Repeated DCE-MRI and DWI in Patients Diagnosed With Prostate Cancer

Role: lead

NCT02420756Completed

Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study

Role: collaborator

NCT00084929Not ApplicableCompleted

The National CT Colonography Trial

Role: lead

NCT00023868Phase 3Terminated

Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)

Role: lead

NCT00028002Phase 2Completed

Neoadjuvant and Adjuvant Imatinib Mesylate in Treating Patients With Primary or Recurrent Malignant Gastrointestinal Stromal Tumor

Role: collaborator

NCT00983697Not ApplicableUnknown

FDG-PET/CT in Assessing the Tumor and Planning Neck Surgery in Patients With Newly Diagnosed H&N Cancer

Role: lead

NCT00132041Not ApplicableCompleted

Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis

Role: lead

NCT00868582Unknown

The National Oncologic PET Registry

Role: lead

NCT00058058Not ApplicableCompleted

Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer

Role: lead

NCT00026247Not ApplicableCompleted

Radiofrequency Ablation in Treating Patients With Bone Metastases

Role: lead

NCT01465425Unknown

Extracolonic Findings on Computed Tomography (CT) Colonography

Role: lead